Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2017, Article ID 7353252, 16 pages
https://doi.org/10.1155/2017/7353252
Research Article

All-Trans Retinoic Acid Modulates TLR4/NF-κB Signaling Pathway Targeting TNF-α and Nitric Oxide Synthase 2 Expression in Colonic Mucosa during Ulcerative Colitis and Colitis Associated Cancer

1Team: Cytokines and NO Synthases-Immunity and Pathogenesis, Laboratory of Cellular and Molecular Biology (LBCM), Faculty of Biological Science, University of Sciences and Technology (USTHB), Algiers, Algeria
2Institut de Biologie de Lille, UMR 8161, CNRS, Institut Pasteur de Lille, Université Lille-Nord de France, Lille, France
3Anatomic Pathology Service, Mustapha Pacha Hospital, Algiers, Algeria
4Department of Gastroenterology, Maillot Hospital, Algiers, Algeria
5Service of Oncology, Rouiba Hospital, Algiers, Algeria

Correspondence should be addressed to Nadira Delhem; rf.lbi@mehled.aridan and Chafia Touil-Boukoffa; rf.oohay@affokuobliuot

Received 5 November 2016; Revised 5 January 2017; Accepted 19 February 2017; Published 20 March 2017

Academic Editor: Kumar S. Bishnupuri

Copyright © 2017 Hayet Rafa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Jemal, F. Bray, M. M. Center, J. Ferlay, E. Ward, and D. Forman, “Global cancer statistics,” CA Cancer Journal for Clinicians, vol. 61, no. 2, pp. 69–90, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. T. A. Ullman and S. H. Itzkowitz, “Intestinal inflammation and cancer,” Gastroenterology, vol. 140, no. 6, pp. 1807–1816, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Ligibel, “Lifestyle factors in cancer survivorship,” Journal of Clinical Oncology, vol. 30, no. 30, pp. 3697–3704, 2012. View at Publisher · View at Google Scholar
  4. E. K. Wei, E. Giovannucci, K. Wu et al., “Comparison of risk factors for colon and rectal cancer,” International Journal of Cancer, vol. 108, no. 3, pp. 433–442, 2004. View at Publisher · View at Google Scholar
  5. T. Hagemann, F. Balkwill, and T. Lawrence, “Inflammation and cancer: a double-edged sword,” Cancer Cell, vol. 12, no. 4, pp. 300–301, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. J. A. Eaden, K. R. Abrams, and J. F. Mayberry, “The risk of colorectal cancer in ulcerative colitis: a meta-analysis,” Gut, vol. 48, no. 4, pp. 526–535, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Rajput and A. Wilber, “Roles of inflammation in cancer initiation, progression, and metastasis,” Frontiers in Bioscience, vol. 2, no. 1, pp. 176–183, 2010. View at Google Scholar · View at Scopus
  8. S. Kraus and N. Arber, “Inflammation and colorectal cancer,” Current Opinion in Pharmacology, vol. 9, no. 4, pp. 405–410, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. L. J. Herrinton, L. Liu, J. D. Lewis, P. M. Griffin, and J. Allison, “Incidence and prevalence of inflammatory bowel disease in a Northern California Managed Care Organization, 1996–2002,” The American Journal of Gastroenterology, vol. 103, no. 8, pp. 1998–2006, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Rafa, M. Amri, H. Saoula et al., “Involvement of interferon-γ in bowel disease pathogenesis by nitric oxide pathway: a study in algerian patients,” Journal of Interferon and Cytokine Research, vol. 30, no. 9, pp. 691–697, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Rafa, H. Saoula, M. Belkhelfa et al., “IL-23/IL-17A axis correlates with the nitric oxide pathway in inflammatory bowel disease: immunomodulatory effect of retinoic acid,” Journal of Interferon and Cytokine Research, vol. 33, no. 7, pp. 355–368, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. C.-C. Lu, H.-C. Kuo, F.-S. Wang, M.-H. Jou, K.-C. Lee, and J.-H. Chuang, “Upregulation of TLRs and IL-6 as a marker in human colorectal cancer,” International Journal of Molecular Sciences, vol. 16, no. 1, pp. 159–177, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Kaczanowska, A. M. Joseph, and E. Davila, “TLR agonists: our best frenemy in cancer immunotherapy,” Journal of Leukocyte Biology, vol. 93, no. 6, pp. 847–863, 2013. View at Publisher · View at Google Scholar
  14. M. T. Abreu, E. T. Arnold, L. S. Thomas et al., “TLR4 and MD-2 expression is regulated by immune-mediated signals in human intestinal epithelial cells,” The Journal of Biological Chemistry, vol. 277, no. 23, pp. 20431–20437, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Kawai and S. Akira, “Signaling to NF-κB by Toll-like receptors,” Trends in Molecular Medicine, vol. 13, no. 11, pp. 460–469, 2007. View at Publisher · View at Google Scholar
  16. Q. Li, S. Withoff, and I. M. Verma, “Inflammation-associated cancer: NF-κB is the lynchpin,” Trends in Immunology, vol. 26, no. 6, pp. 318–325, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Pfeffer, T. Matsuyama, T. M. Kündig et al., “Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection,” Cell, vol. 73, no. 3, pp. 457–467, 1993. View at Publisher · View at Google Scholar · View at Scopus
  18. R. M. Locksley, N. Killeen, and M. J. Lenardo, “The TNF and TNF receptor superfamilies: integrating mammalian biology,” Cell, vol. 104, no. 4, pp. 487–501, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. R. V. Horssen, T. L. M. Ten Hagen, and A. M. M. Eggermont, “TNF-α in cancer treatment: molecular insights, antitumor effects, and clinical utility,” The Oncologist, vol. 11, pp. 397–408, 2006. View at Publisher · View at Google Scholar
  20. G. A. Duque and A. Descoteaux, “Macrophage cytokines: involvement in immunity and infectious diseases,” Frontiers in Immunology, vol. 5, article 491, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. G. Kolios, V. Valatas, and S. G. Ward, “Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle,” Immunology, vol. 113, no. 4, pp. 427–437, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. R. G. Knowles and S. Moncada, “Nitric oxide synthases in mammals,” Biochemical Journal, vol. 298, no. 2, pp. 249–258, 1994. View at Publisher · View at Google Scholar · View at Scopus
  23. J. C. Drapier, “Monoxyde d'azote et macrophages,” Pathologie Biologie, vol. 45, pp. 110–114, 1997. View at Google Scholar
  24. B. J. R. Whittle, “Nitric oxide in physiology and pathology,” The Histochemical Journal, vol. 27, no. 10, pp. 727–737, 1995. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Jaiswal, N. F. Larusso, and G. J. Gores, “Nitric oxide in gastrointestinal epithelial cell carcinogenesis: linking inflammation to oncogenesis,” American Journal of Physiology - Gastrointestinal and Liver Physiology, vol. 281, no. 3, pp. G626–G634, 2001. View at Google Scholar · View at Scopus
  26. A. Piechota-Polanczyk and J. Fichna, “Review article: the role of oxidative stress in pathogenesis and treatment of inflammatory bowel diseases,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 387, no. 7, pp. 605–620, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Luu, A. K. Arrington, H. F. Schoellhammer, G. Singh, and J. Kim, “Targeted therapies in colorectal cancer: surgical considerations,” Journal of Gastrointestinal Oncology, vol. 4, pp. 328–336, 2013. View at Google Scholar
  28. P. Hassanzadeh, “Colorectal cancer and NF-κB signaling pathway,” Gastroenterology and Hepatology from Bed to Bench, vol. 4, no. 3, pp. 127–132, 2011. View at Google Scholar · View at Scopus
  29. M. Shimizu, K. Takai, and H. Moriwaki, “Strategy and mechanism for the prevention of hepatocellular carcinoma: phosphorylated retinoid X receptor α is a critical target for hepatocellular carcinoma chemoprevention,” Cancer Science, vol. 100, no. 3, pp. 369–374, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. M. R. Carratù, C. Marasco, G. Mangialardi, and A. Vacca, “Retinoids: novel immunomodulators and tumour-suppressive agents?” British Journal of Pharmacology, vol. 167, no. 3, pp. 483–492, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Shirakami, H. Sakai, and M. Shimizu, “Retinoid roles in blocking hepatocellular carcinoma,” Hepatobiliary Surgery and Nutrition, vol. 4, pp. 222–228, 2015. View at Google Scholar
  32. C. C. Applegate and M. A. Lane, “Role of retinoids in the prevention and treatment of colorectal cancer,” World Journal of Gastrointestinal Oncology, vol. 7, pp. 184–203, 2015. View at Google Scholar
  33. N. Bushue and Y.-J. Y. Wan, “Retinoid pathway and cancer therapeutics,” Advanced Drug Delivery Reviews, vol. 62, no. 13, pp. 1285–1298, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. D. J. Mangelsdorf and R. M. Evans, “The RXR heterodimers and orphan receptors,” Cell, vol. 83, no. 6, pp. 841–850, 1995. View at Publisher · View at Google Scholar · View at Scopus
  35. D. R. Soprano, P. Qin, and K. J. Soprano, “Retinoic acid receptors and cancers,” Annual Review of Nutrition, vol. 24, pp. 201–221, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. K. Mehta, T. McQueen, S. Tucker, R. Pandita, and B. B. Aggarwal, “Inhibition of all-trans-retinoic acid of tumor necrosis factor and nitric oxide production by peritoneal macrophages,” Journal of Leukocyte Biology, vol. 55, no. 3, pp. 336–342, 1994. View at Google Scholar · View at Scopus
  37. P. K. Datta, R. S. Reddy, and E. A. Lianos, “Effects of all-trans-retinoic acid (atRA) on inducible Nitric oxide synthase (iNOS) activity and transforming growth factor beta-1 production in experimental anti-GBM antibody-mediated glomerulonephritis,” Inflammation, vol. 25, no. 6, pp. 351–359, 2001. View at Publisher · View at Google Scholar · View at Scopus
  38. B.-H. Kim, K.-S. Kang, and Y.-S. Lee, “Effect of retinoids on LPS-induced COX-2 expression and COX-2 associated PGE2 release from mouse peritoneal macrophages and TNF-α release from rat peripheral blood mononuclear cells,” Toxicology Letters, vol. 150, no. 2, pp. 191–201, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. N. Behairi, M. Belkhelfa, H. Mesbah-Amroun et al., “All- trans -retinoic acid modulates nitric oxide and interleukin-17A production by peripheral blood mononuclear cells from patients with Alzheimer's disease,” NeuroImmunoModulation, vol. 22, no. 6, pp. 385–393, 2015. View at Publisher · View at Google Scholar · View at Scopus
  40. G. Kolios, K. L. Wright, J. D. Linehan, D. A. Robertson, and J. Westwick, “Interleukin-13 inhibits nitric oxide production in human colonic mucosa,” Hepato-Gastroenterology, vol. 47, no. 33, pp. 714–717, 2000. View at Google Scholar · View at Scopus
  41. C. Touil-Boukoffa, B. Bauvois, J. Sancéau, B. Hamrioui, and J. Wietzerbin, “Production of nitric oxide (NO) in human hydatidosis: relationship between nitrite production and interferon-γ levels,” Biochimie, vol. 80, no. 8-9, pp. 739–744, 1998. View at Publisher · View at Google Scholar · View at Scopus
  42. J. Terzić, S. Grivennikov, E. Karin, and M. Karin, “Inflammation and colon cancer,” Gastroenterology, vol. 138, no. 6, pp. 2101.e5–2114.e5, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. L. Klampfer, “Cytokines, inflammation and colon cancer,” Current Cancer Drug Targets, vol. 11, no. 4, pp. 451–464, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. E. Viennois, F. Chen, and D. Merlin, “NF-κB pathway in colitis-associated cancers,” Translational Gastrointestinal Cancer, vol. 2, pp. 21–29, 2013. View at Google Scholar
  45. J. Marx, “Inflammation and cancer: the link grows stronger,” Science, vol. 306, no. 5698, pp. 966–968, 2004. View at Publisher · View at Google Scholar · View at Scopus
  46. Y.-J. Surh, A. M. Bode, and Z. Dong, “Breaking the NF-κB and STAT3 alliance inhibits inflammation and pancreatic tumorigenesis,” Cancer Prevention Research, vol. 3, no. 11, pp. 1379–1381, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Gambhir, D. Vyas, M. Hollis, A. Aekka, and A. Vyas, “Nuclear factor kappa B role in inflammation associated gastrointestinal malignancies,” World Journal of Gastroenterology, vol. 21, no. 11, pp. 3174–3183, 2015. View at Publisher · View at Google Scholar · View at Scopus
  48. H. Jain, N. Dhingra, T. Narsinghani, and R. Sharma, “Insights into the mechanism of natural terpenoids as NF-κB inhibitors: an overview on their anticancer potential,” Experimental Oncology, vol. 38, pp. 158–168, 2016. View at Google Scholar
  49. S. Papa, F. Zazzeroni, C. G. Pham, C. Bubici, and G. Franzoso, “Linking JNK signaling to NF-κB: a key to survival,” Journal of Cell Science, vol. 117, no. 22, pp. 5197–5208, 2004. View at Publisher · View at Google Scholar · View at Scopus
  50. P. S. Simon, S. K. Sharman, C. Lu et al., “The NF-κB p65 and p50 homodimer cooperate with IRF8 to activate iNOS transcription,” BMC Cancer, vol. 15, no. 1, article 770, 2015. View at Publisher · View at Google Scholar · View at Scopus
  51. B. K. Popivanova, K. Kitamura, Y. Wu et al., “Blocking TNF-α in mice reduces colorectal carcinogenesis associated with chronic colitis,” The Journal of Clinical Investigation, vol. 118, no. 2, pp. 560–570, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. M. Onizawa, T. Nagaishi, T. Kanai et al., “Signaling pathway via TNF-α/NF-κB in intestinal epithelial cells may be directly involved in colitis-associated carcinogenesis,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 296, no. 4, pp. G850–G859, 2009. View at Publisher · View at Google Scholar · View at Scopus
  53. M. F. Neurath, I. Fuss, M. Pasparakis et al., “Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice,” European Journal of Immunology, vol. 27, no. 7, pp. 1743–1750, 1997. View at Publisher · View at Google Scholar · View at Scopus
  54. H. Masuda, S. Iwai, T. Tanaka, and S. Hayakawa, “Expression of IL-8, TNF-alpha and IFN-gamma m-RNA in ulcerative colitis, particularly in patients with inactive phase,” Journal of clinical & laboratory immunology, vol. 46, no. 3, pp. 111–123, 1995. View at Google Scholar · View at Scopus
  55. S. Kim, T. O. Keku, C. Martin et al., “Circulating levels of inflammatory cytokines and risk of colorectal adenomas,” Cancer Research, vol. 68, no. 1, pp. 323–328, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. T. W. H. Li, H. Yang, H. Peng, M. Xia, J. M. Mato, and S. C. Lu, “Effects of S-adenosylmethionine and methylthioadenosine on inflammation-induced colon cancer in mice,” Carcinogenesis, vol. 33, no. 2, pp. 427–435, 2012. View at Publisher · View at Google Scholar · View at Scopus
  57. B. K. Popivanova, K. Kitamura, Y. Wu et al., “Blocking TNF-α in mice reduces colorectal carcinogenesis associated with chronic colitis,” Journal of Clinical Investigation, vol. 118, no. 2, pp. 560–570, 2008. View at Publisher · View at Google Scholar · View at Scopus
  58. N. Mukaida, S.-I. Sasakki, and B. K. Popivanova, “Tumor necrosis factor (TNF) and chemokines in colitis-associated cancer,” Cancers, vol. 3, no. 3, pp. 2811–2826, 2011. View at Publisher · View at Google Scholar · View at Scopus
  59. H. Seno, M. Oshima, T.-O. Ishikawa et al., “Cyclooxygenase 2- and prostaglandin E2 receptor EP2-dependent angiogenesis in ApcΔ716 mouse intestinal polyps,” Cancer Research, vol. 62, no. 2, pp. 506–511, 2002. View at Google Scholar · View at Scopus
  60. M. D. Castellone, H. Teramoto, B. O. Williams, K. M. Druey, and J. S. Gutkind, “Medicine: prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-β-catenin signaling axis,” Science, vol. 310, no. 5753, pp. 1504–1510, 2005. View at Publisher · View at Google Scholar · View at Scopus
  61. M. Jaiswal, N. F. Larusso, and G. J. Gores, “Nitric oxide in gastrointestinal epithelial cell carcinogenesis: linking inflammation to oncogenesis,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 281, no. 3, pp. G626–G634, 2001. View at Google Scholar · View at Scopus
  62. I. I. Singer, D. W. Kawka, S. Scott et al., “Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease,” Gastroenterology, vol. 111, no. 4, pp. 871–885, 1996. View at Publisher · View at Google Scholar · View at Scopus
  63. S. S. Mirvish, “Role of N-nitroso-compounds (NOC) and nitrosation in etiology of gastric esophageal, nasopharyngeal and bladder cancer and contribution to cancer of known exposure to NOC,” Cancer Letters, vol. 93, pp. 17–48, 1995. View at Google Scholar
  64. C. V. Rao, “Nitric oxide signaling in colon cancer chemoprevention,” Mutation Research, vol. 555, no. 1-2, pp. 107–119, 2004. View at Publisher · View at Google Scholar · View at Scopus
  65. K. Bian, F. Ghassemi, A. Sotolongo et al., “NOS-2 signaling and cancer therapy,” IUBMB Life, vol. 64, no. 8, pp. 676–683, 2012. View at Publisher · View at Google Scholar · View at Scopus
  66. E. Cario and D. K. Podolsky, “Differential alteration in intestinal epithelial cell expression of Toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease,” Infection and Immunity, vol. 68, no. 12, pp. 7010–7017, 2000. View at Publisher · View at Google Scholar · View at Scopus
  67. L. Frolova, P. Drastich, P. Rossmann, K. Klimesova, and H. Tlaskalova-Hogenova, “Expression of Toll-like receptor 2 (TLR2), TLR4, and CD14 in biopsy samples of patients with inflammatory bowel diseases: upregulated expression of TLR2 in terminal ileum of patients with ulcerative colitis,” Journal of Histochemistry and Cytochemistry, vol. 56, no. 3, pp. 267–274, 2008. View at Publisher · View at Google Scholar · View at Scopus
  68. R. Y. C. Hsu, H. F. C. Chan, D. J. Spicer et al., “Liver metastasis 1 integrin-mediated cell adhesion and β cells increases LPS-induced TLR4 signaling in human colorectal cancer,” Cancer Research, vol. 71, pp. 1989–1998, 2011. View at Google Scholar
  69. M. Fukata, A. Chen, A. S. Vamadevan et al., “Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors,” Gastroenterology, vol. 133, no. 6, pp. 1869.e1–1869.e14, 2007. View at Publisher · View at Google Scholar · View at Scopus
  70. M. Fukata, Y. Hernandez, D. Conduah et al., “Innate immune signaling by toll-like receptor-4 (TLR4) shapes the inflammatory microenvironment in colitis-associated tumors,” Inflammatory Bowel Diseases, vol. 15, no. 7, pp. 997–1006, 2009. View at Publisher · View at Google Scholar · View at Scopus
  71. Y. Hernandez, J. Sotolongo, K. Breglio et al., “The role of prostaglandin E2 (PGE2) in toll-like receptor 4 (TLR4)-mediated colitis-associated neoplasia,” BMC Gastroenterology, vol. 10, article 82, 2010. View at Publisher · View at Google Scholar · View at Scopus
  72. B. S. Park, D. H. Song, H. M. Kim, B.-S. Choi, H. Lee, and J.-O. Lee, “The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex,” Nature, vol. 458, no. 7242, pp. 1191–1195, 2009. View at Publisher · View at Google Scholar · View at Scopus
  73. Y.-C. Lu, W.-C. Yeh, and P. S. Ohashi, “LPS/TLR4 signal transduction pathway,” Cytokine, vol. 42, no. 2, pp. 145–151, 2008. View at Publisher · View at Google Scholar · View at Scopus
  74. K. A. Fitzgerald, D. C. Rowe, B. J. Barnes et al., “LPS-TLR4 signaling to IRF-3/7 and NF-κB involves the toll adapters TRAM and TRIF,” Journal of Experimental Medicine, vol. 198, no. 7, pp. 1043–1055, 2003. View at Publisher · View at Google Scholar · View at Scopus
  75. L. Andresen, V. L. Jørgensen, A. Perner, A. Hansen, J. Eugen-Olsen, and J. Rask-Madsen, “Activation of nuclear factor κB in colonic mucosa from patients with collagenous and ulcerative colitis,” Gut, vol. 54, no. 4, pp. 503–509, 2005. View at Publisher · View at Google Scholar · View at Scopus
  76. F. R. Greten, L. Eckmann, T. F. Greten et al., “IKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer,” Cell, vol. 118, no. 3, pp. 285–296, 2004. View at Publisher · View at Google Scholar · View at Scopus
  77. M. J. Waldner and M. F. Neurath, “Mechanisms of immune signaling in colitis-associated cancer,” Cellular and Molecular Gastroenterology and Hepatology, vol. 1, no. 1, pp. 6–16, 2015. View at Publisher · View at Google Scholar · View at Scopus
  78. R. Molenaar, M. Knippenberg, G. Goverse et al., “Expression of retinaldehyde dehydrogenase enzymes in mucosal dendritic cells and gut-draining lymph node stromal cells is controlled by dietary vitamin A,” The Journal of Immunology, vol. 186, no. 4, pp. 1934–1942, 2011. View at Publisher · View at Google Scholar · View at Scopus
  79. F. Stevison, J. Jing, S. Tripathy, and N. Isoherranen, “Role of retinoic acid-metabolizing cytochrome P450s, CYP26, in inflammation and cancer,” Advances in Pharmacology, vol. 74, pp. 373–412, 2015. View at Publisher · View at Google Scholar · View at Scopus
  80. M. Raverdeau and K. H. G. Mills, “Modulation of T cell and innate immune responses by retinoic acid,” Journal of Immunology, vol. 192, no. 7, pp. 2953–2958, 2014. View at Publisher · View at Google Scholar · View at Scopus
  81. N. Bhattacharya, R. Yuan, T. Prestwood et al., “Normalizing microbiota-induced retinoic acid deficiency stimulates protective CD8+ T cell-mediated immunity in colorectal cancer,” Immunity, vol. 45, no. 3, pp. 641–655, 2016. View at Publisher · View at Google Scholar
  82. E. S. Kropotova, O. L. Zinovieva, A. F. Zyryanova et al., “Altered expression of multiple genes involved in retinoic acid biosynthesis in human colorectal cancer,” Pathology and Oncology Research, vol. 20, no. 3, pp. 707–717, 2014. View at Publisher · View at Google Scholar · View at Scopus
  83. A. C. Ross and R. Zolfaghari, “Cytochrome P450s in the regulation of cellular retinoic acid metabolism,” Annual Review of Nutrition, vol. 31, pp. 65–87, 2011. View at Publisher · View at Google Scholar · View at Scopus
  84. G. T. Brown, B. G. Cash, D. Blihoghe, P. Johansson, A. Alnabulsi, and G. I. Murray, “The expression and prognostic significance of retinoic acid metabolising enzymes in colorectal cancer,” PLoS ONE, vol. 9, no. 3, Article ID e90776, 2014. View at Publisher · View at Google Scholar · View at Scopus
  85. S.-Y. Sun, “Retinoic acid receptor β and colon cancer,” Cancer Biology and Therapy, vol. 3, no. 1, pp. 87–88, 2004. View at Publisher · View at Google Scholar · View at Scopus
  86. D. N. Shelton, I. T. Sandoval, A. Eisinger et al., “Up-regulation of CYP26A1 in adenomatous polyposis coli-deficient vertebrates via a WNT-dependent mechanism: implications for intestinal cell differentiation and colon tumor development,” Cancer Research, vol. 66, no. 15, pp. 7571–7577, 2006. View at Publisher · View at Google Scholar · View at Scopus
  87. S. Y. Sun and R. Lotan, “Retinoids and their receptors in cancer development and chemoprevention,” Critical Reviews in Oncology/Hematology, vol. 41, no. 1, pp. 41–55, 2002. View at Google Scholar
  88. Y. Zheng, P. M. Kramer, R. A. Lubet, V. E. Steele, G. J. Kelloff, and M. A. Pereira, “Effect of retinoids on AOM-induced colon cancer in rats: modulation of cell proliferation, apoptosis and aberrant crypt foci,” Carcinogenesis, vol. 20, no. 2, pp. 255–260, 1999. View at Publisher · View at Google Scholar · View at Scopus
  89. B. Nicke, E.-O. Riecken, and S. Rosewicz, “Induction of retinoic acid receptor β mediates growth inhibition in retinoid resistant human colon carcinoma cells,” Gut, vol. 45, no. 1, pp. 51–57, 1999. View at Publisher · View at Google Scholar · View at Scopus
  90. L. Møllersen, J. E. Paulsen, H. B. Ølstørn, H. K. Knutsen, and J. Alexander, “Dietary retinoic acid supplementation stimulates intestinal tumour formation and growth in multiple intestinal neoplasia (Min)/+ mice,” Carcinogenesis, vol. 25, no. 1, pp. 149–153, 2004. View at Publisher · View at Google Scholar · View at Scopus
  91. G.-S. Oh, H.-O. Pae, W.-G. Seo et al., “Inhibitory effect of retinoic acid on expression of inducible nitric oxide synthase gene in L929 cells,” Immunopharmacology and Immunotoxicology, vol. 23, no. 3, pp. 335–342, 2001. View at Publisher · View at Google Scholar · View at Scopus
  92. A. Sirsjö, A. C. Gidlöf, A. Olsson et al., “Retinoic acid inhibits nitric oxide synthase-2 expression through the retinoic acid receptor-α,” Biochemical and Biophysical Research Communications, vol. 270, no. 3, pp. 846–851, 2000. View at Publisher · View at Google Scholar · View at Scopus
  93. Q. Yang, T. Sakurai, and K. Kakudo, “Retinoid, retinoic acid receptor β and breast cancer,” Breast Cancer Research and Treatment, vol. 76, no. 2, pp. 167–173, 2002. View at Publisher · View at Google Scholar · View at Scopus
  94. R. Schule, P. Rangarajan, N. Yang et al., “Retinoic acid is a negative regulator of AP-1-responsive genes,” Proceedings of the National Academy of Sciences, vol. 88, no. 14, pp. 6092–6096, 1991. View at Publisher · View at Google Scholar
  95. S.-Y. Na, B. Y. Kang, S. W. Chung et al., “Retinoids inhibit interleukin-12 production in macrophages through physical associations of retinoid X receptor and NFκB,” Journal of Biological Chemistry, vol. 274, no. 12, pp. 7674–7680, 1999. View at Publisher · View at Google Scholar · View at Scopus
  96. A. M. Jiménez-Lara, A. Aranda, and H. Gronemeyer, “Retinoic acid protects human breast cancer cells against etoposide-induced apoptosis by NF-kappaB-dependent but cIAP2-independent mechanisms,” Molecular Cancer, vol. 9, article 15, 2010. View at Publisher · View at Google Scholar
  97. Q.-W. Xie, R. Whisnant, and C. Nathan, “Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon γ and bacterial lipopolysaccharide,” Journal of Experimental Medicine, vol. 177, no. 6, pp. 1779–1784, 1993. View at Publisher · View at Google Scholar · View at Scopus
  98. W.-H. Choi, K.-A. Ji, S.-B. Jeon et al., “Anti-inflammatory roles of retinoic acid in rat brain astrocytes: suppression of interferon-γ-induced JAK/STAT phosphorylation,” Biochemical and Biophysical Research Communications, vol. 329, no. 1, pp. 125–131, 2005. View at Publisher · View at Google Scholar · View at Scopus
  99. S. T. Dheen, Y. Jun, Z. Yan, S. S. W. Tay, and E. A. Ling, “Retinoic acid inhibits expression of TNF-α and iNOS in activated rat microglia,” Glia, vol. 50, no. 1, pp. 21–31, 2005. View at Publisher · View at Google Scholar · View at Scopus
  100. K. Hirokawa, K. M. O'Shaughnessy, P. Ramrakha, and M. R. Wilkins, “Inhibition of nitric oxide synthesis in vascular smooth muscle by retinoids,” British Journal of Pharmacology, vol. 113, no. 4, pp. 1448–1454, 1994. View at Publisher · View at Google Scholar · View at Scopus
  101. K. Mehta, T. M. Queen, S. Tucker, R. Pandita, and B. B. Aggarwal, “Inhibition by all-trans-retinoic acid of tumor necrosis factor and nitric oxide production by peritoneal macrophages,” Journal of Leukocyte Biology, vol. 55, pp. 336–342, 1994. View at Google Scholar
  102. S. Grosjean, Y. Devaux, C. Seguin et al., “Retinoic acid attenuates inducible nitric oxide synthase (NOS2) activation in cultured rat cardiac myocytes and microvascular endothelial cells,” Journal of Molecular and Cellular Cardiology, vol. 33, no. 5, pp. 933–945, 2001. View at Publisher · View at Google Scholar · View at Scopus